Publications by authors named "Eva Schlein"

Claim this Profile
P
Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine.
Sara Lopes van den Broek, Jonas Eriksson, Qiaojun Yang, Nadja M Bucher, Eva Schlein

Transl Neurodegener· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorine-18 ImmunoPET Imaging of Antibody Brain Kinetics and Amyloid-Beta Pathology.
Eva Schlein, Sara Lopes van den Broek, Tiffany Dallas, Ken G Andersson, Stina Syvänen

ACS Pharmacol Transl Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose.
Gillian Bonvicini, Sunitha Singh, Lisa Sandersjöö, Tiffany Dallas, Eva Schlein

Fluids Barriers CNS· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing neonatal Fc receptor binding enhances clearance and brain-to-blood ratio of TfR-delivered bispecific amyloid-β antibody.
Eva Schlein, Ken G Andersson, Tiffany Dallas, Stina Syvänen, Dag Sehlin

MAbs· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET.
Eva Schlein, Johanna Rokka, Luke R Odell, Sara Lopes van den Broek, Matthias M Herth

EJNMMI Radiopharm Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging.
Eva Schlein, Stina Syvänen, Johanna Rokka, Tobias Gustavsson, Raffaella Rossin

Mol Pharm· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET Imaging in Preclinical Anti-Aβ Drug Development.
Stina Syvänen, Silvio R Meier, Sahar Roshanbin, Mengfei Xiong, Rebecca Faresjö, Eva Schlein

Pharm Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo imaging of synaptic density with [C]UCB-J PET in two mouse models of neurodegenerative disease.
Mengfei Xiong, Sahar Roshanbin, Johanna Rokka, Eva Schlein, Martin Ingelsson

Neuroimage· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved synthesis of SV2A targeting radiotracer [C]UCB-J.
Johanna Rokka, Eva Schlein, Jonas Eriksson

EJNMMI Radiopharm Chem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis